key: cord-0984827-6fgi1pvf
authors: Bhujel, Nabina; Zaheer, Khaleda; Singh, Rabindra P
title: Oral mucosal lesions in patients with COVID-19: a systematic review
date: 2021-06-25
journal: Br J Oral Maxillofac Surg
DOI: 10.1016/j.bjoms.2021.06.011
sha: b77cfb64a5fab6f53ab5b0a8494b30e428b862cf
doc_id: 984827
cord_uid: 6fgi1pvf

COVID-19 is a new disease which mainly presents with respiratory symptoms, however can present with a multitude of signs and symptoms affecting various body systems. Several oral manifestations related to COVID-19 have also been reported. We carried out a systematic review to explore the types of oral mucosal lesions that have been reported in COVID-19 related literature up to the date of 25th of March 2021. A structured electronic databases search using Medline, Embase and CINAHL as well as gray literature search using Google Scholar revealed a total of 322 studies. After removal of duplicates and the primary and secondary filtering process, 12 studies were included for final appraisal. We have identified several different types of oral mucosal lesions in patients with COVID-19 infection, present at various locations within the oral cavity. Most of the studies appraised in this review were of high risk of bias according to the Joanna Briggs Institute checklist. The current published literature does not allow differentiation as to whether the oral lesions are caused by the viral infection itself or instead related to oral manifestations secondary to existing patient comorbidities or treatment instigated to combat the disease. It is important for healthcare professionals to be aware of the possible link between COVID-19 and oral mucosal lesions, and we hereby discuss our findings.

The COVID-19 pandemic commenced in December 2019 and has so far affected 163 million population with over 3 million deaths worldwide. 1 The pandemic appears to be far from over with various reports of emerging new variants despite ongoing efforts on worldwide vaccination rollout, suggesting that there is continued need for the medical practitioners to remain up-to-date with their knowledge of signs and symptoms of this condition. It has been suggested that the angiotensin-converting enzyme 2 (ACE2) receptors, which are highly expressed in oral tissues such as tongue, epithelial linings of salivary ducts, salivary glands and taste buds, may act as entry points for the SARS-CoV-2 virus. 2 The oral mucosa may therefore act as a portal of entry for this virus leading to colonisation and resulting in oral signs and symptoms. Acute loss or altered sense of taste and smell have been noted among the most common symptoms with the prevalence rate of 45%, leading to these symptoms being formally recognised by the United Kingdom National Health Service among the main symptoms for suspicion of COVID-19 infection. 3, 4 J o u r n a l P r e -p r o o f 3 A number of oral mucosal lesions have been reported in COVID-19 patients which include erythematous plaque, ulcers, blisters, bullae, petechiae, mucositis and desquamative gingivitis. 3 The most commonly involved oral sites have been reported as tongue, palate, lips, gingiva and buccal mucosa. 3, 5 It is unclear as to whether the described oral lesions are manifestations of COVID-19 or instead are the results of immunosuppression and side effects of the treatment. It is well established that oral lesions of various types are manifestations of several other virus illnesses, 6 and therefore it is plausible that the SARS-CoV-2 virus also causes oral lesions.

The knowledge of oral lesions is important for all healthcare professionals, but in particular the general dental and medical practitioners as well as specialists in oral medicine and oral & maxillofacial surgery. The aim of this systematic review was to identify and consolidate the types of oral mucosal lesions in patients with disease and also to report on the location of these lesions within the oral mucosa.

A protocol for the systematic review was developed and registered at the International Prospective Register of Systematic Reviews (PROSPERO) database under registration CRD42021245738. 7

Observational studies which investigated the prevalence of oral lesions were included and PECO (Population, Exposure, Comparator, Outcome) strategy was utilised. Case reports, review articles and conference abstracts were excluded, J o u r n a l P r e -p r o o f however case series were included so that more studies would be captured by the systematic review. Only the studies published in English language were included.

A structured electronic search was carried out using the electronic databases Medline, Embase and CINAHL. Gray literature was searched using Google Scholar.

Reference lists of the included articles were also checked to identify any other potential studies. The search included all articles published until 25th March 2021 across all mentioned databases. Search terms using keywords and medical subject headings utilised in this review were detailed in the published protocol. 7

Primary screening was carried out by two authors (NB and KZ) who independently reviewed the titles and abstracts of all articles identified by the electronic databases.

For the studies that appear to meet the inclusion criteria, a secondary filtering was carried out by reviewing the full text articles independently by the above-mentioned authors.

Standardised data extraction proforma was employed to all the included studies to make meaningful comparison among the studies. Any disagreement and discrepancy between the two authors (NB and KZ) was either resolved by discussion or after discussion with the third author (RPS). Two authors (NB and KZ) collected the required information using the standardised proforma and the third author (RPS) checked and confirmed the data collected. Data collection proforma included patient demographics, type of oral lesions and the site affected by oral lesions.

Narrative synthesis of the included studies was carried out. Meta analysis was not planned as we did not expect homogeneity of the studies. For the risk of bias, two reviewers (NB and KZ) independently assessed the studies as per Joanna Briggs Institute tool. 8 The studies were classified as high, medium and low risk of bias when the studies reached 49% 'yes', 50-69% 'yes' and more than 70% 'yes' respectively.

There were a total of 290 studies initially identified from the electronic databases with further 32 studies from gray literature to the date of 25th March 2021. The outcomes of primary and secondary screening, duplicates removal and final inclusions are shown in the flowchart (see Figure 1 ). The final count included 12 studies which were deemed suitable for appraisal in this systematic review.

The characteristics of the studies including demographic details and oral lesions reported is presented in Table 1 .

Risk of bias assessment as per Joanna Briggs Critical Appraisal Tool of each of the included studies is indicated in Table 1 . Most of the studies were at high risk of bias.

Description of oral mucosal lesions were reported in all included studies, however there was no consistency in the mode of reporting of such lesions. One study reported oral lesions along with oral/ dental pain, pain in jaw joints and halitosis. 9 This type of reporting of both signs and symptoms together made it difficult to establish the specific features of oral mucosal lesions. It is also unclear whether the pain and other symptoms were a result of the stated oral lesions. Some studies reported changes in oral cavity but the type of lesions were unspecified. 10, 11 Oral mucosal lesions reported were of several types in various locations (See Table   1 and 2). The most commonly reported oral lesion was oral ulceration which was reported in up to 47% (n=27) of the cases in one study. 12 Other common oral mucosal changes included changes in the tongue including strawberry tongue, geographic tongue, fissured tongue and macroglossia which has even led to a terminology 'covid tongue', 13, 14, 15, 16 with one study reporting these changes in up to 25% of the cases (n=10). 16 Gingival manifestations included necrotic gingivitis and desquamative gingivitis. 15, 17 Haemorrhagic lesions/ ulcers were also reported in up to 50% of the cases in two studies, however the sample size was very small. 18, 19 Herpetic stomatitis were noted in two case series appraised in this review. 17, 20 The most common location of the lesions was the tongue followed by palate and buccal/ labial mucosa and gingiva. One study only reported recurrent aphthous stomatitis in COVID-19 patients, and one study reported oral changes but failed to describe the type of changes noted. 10, 11

A summary of types of oral lesions identified in this systematic review are listed in Table 2 . 

This systematic review has revealed several interesting findings which are worthy of discussion. The results showed that the oral lesions stated above could be manifestations of COVID-19, however it is not possible to entirely differentiate from lesions that have occurred due to treatment of this condition.

Exploration of manifestation of a disease ideally would require an exposure group and the control group for comparison. As COVID-19 is a new disease, so far there has not been a large-scale observational study on this topic and most of the studies appraised in this systematic review lacked the control group. Of the twelve studies appraised in this review, seven were of cross-sectional design and three were case series. We excluded case reports, letters, reviews and conference abstracts to improve the quality of the systematic review. Language of publications included in J o u r n a l P r e -p r o o f this review was restricted to English, which was to ensure that the review was carried out in a timely fashion without any financial implication for language translation services. This may have led to publication bias.

The observational studies should ideally be reported using Strengthening the Reporting of Observational Studies in Epidemiology (STROBE), 21 There was only one study in this review where there was a comparator group: patients with recurrent aphthous ulceration and COVID-19 as compared to patients with COVID-19 without recurrent aphthous ulceration. 11 This study only focused on recurrent aphthous ulceration, which limits its scope in determining the causal link to various other types of lesions. Nevertheless, they stated a strong association between COVID-19 and recurrent aphthous stomatitis. 11 Although oral lesions appear during the illness with COVID-19, it has not been possible to differentiate whether the oral lesions were complications of the disease or Some studies attempted to exclude patients who had a history of oral ulceration or co-existing medical condition to reduce confounding bias, however the oral mucosal lesions could have been a result of the treatment they had received which was again not possible to diffrenetiate. 22 It is also important to bear in mind that COVID-19 was more severe in older age group. This age group may have higher levels of 

World Health Organisation. WHO Coronavirus (COVID-19) Dashboard

Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity

Oral Manifestations in Patients with COVID-19: A Living Systematic Review

Main symptoms of coronavirus (COVID-19)

Oral manifestations of COVID-19 disease: A review article

Atlas Oral Maxillofac Surg Clin North Am

Oral lesions in patients with COVID-19: a systematic review

The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence

Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population

Pediatric COVID-19 Cases: A Retrospective Study

Increased odds ratio for COVID-19 in patients with recurrent aphthous stomatitis

Oral lesions in Covid 19 positive patients

Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients

Non-specific oral and cutaneous manifestations of Coronavirus Disease 2019 in children

Covid-19 Symptomatic Patients with Oral Lesions: Clinical and Histopathological Study on 123 Cases of the University Hospital Policlinic of Bari with a Purpose of a New Classification

Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study

Oral vesiculobullous lesions associated with SARS-CoV-2 infection

Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?. Oral Surg Oral Med Oral Pathol Oral Radiol

Report of four cases. Are they a true sign of COVID-19 disease?

Oral ulceration and blistering in patients with COVID-19

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2

Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19

The authors would like to thank Ms F. Mina Shaibatzadeh of University of Southampton Health Sciences Library for carrying out electronic searches and supplying the list of articles.

The authors declare no conflict of interest.

Not applicable.